Abridge

abridge.com

Generative AI for Clinical Conversations

LBX PPS

1Y return

$179

Implied Valuation

$6.0B

+13.0% premium

Last Round

$158

Later Stage VC · $5.3B

Activity

1.6

#85 most active

Price per share

12M · USD

Loading chart...

Funding history

$M raised · $B post-money

Loading chart...

Signals

1 latest

May 26

Abridge Named to CNBC Disruptor 50 List

CNBC featured Abridge on its Disruptor 50 list, highlighting the company's use of AI to disrupt the healthcare space with its ambient clinical documentation platform.

Source: CNBC